$MFST Medifirst is pleased to announce that it has successfully completed a Skin Surface Temperature Study as requested by the FDA as part of their most recent request for more information. Using live human subjects, the test was required to show that the Time Machine Laser can maintain skin temperature within a specified range of degrees for a specific treatment times and other details as related to the usage on the live subjects. The test was performed by Laser Lab Corp under its approved IRB (Institutional Review Board) status to perform clinical studies for new possible usages, protocols and treatments for the Time Machine Laser Series.
(0)
(0)
Medifirst Solutions Inc. (MFST) Stock Research Links